Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell Populations
- 31 January 2002
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 160 (1), 237-246
- https://doi.org/10.1016/s0002-9440(10)64367-2
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Involvement of the [uPAR:uPA:PAI-1:LRP] Complex in Human Myogenic Cell MotilityExperimental Cell Research, 2000
- Regulation of Urokinase Receptor Transcription by Ras- and Rho-Family GTPasesBiochemical and Biophysical Research Communications, 2000
- Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase ActivityPublished by Elsevier BV ,2000
- Stromal Cell-derived Factor-1α Associates with Heparan Sulfates through the First β-Strand of the ChemokinePublished by Elsevier BV ,1999
- Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and α2-macroglobulin receptor in human breast carcinomasInternational Journal of Cancer, 1996
- Cell Migration: A Physically Integrated Molecular ProcessCell, 1996
- The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I ComplexesPublished by Elsevier BV ,1995
- Substrates for Astrocytoma InvasionNeurosurgery, 1995
- Very low density lipoprotein receptor from mammary gland and mammary epithelial cell lines binds and mediates endocytosis of Mr, 40,000 receptor associated proteinFEBS Letters, 1994
- Autocrine saturation of pro-urokinase receptors on human A431 cellsCell, 1986